Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:
Display all Answers
We plan to report on BELVIQ’s performance during our quarterly financial results announcements.
Subscription services that are available for a fee track and provide BELVIQ prescription data. At times, this information is reported on by the research analyst community and media.
Arena’s fiscal year ends on December 31.
You can sign up for email alerts to receive notification of announcements and upcoming events here.
At this time Arena does not offer a direct stock purchase plan.
Aug 15, 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Aug 8, 2016
Arena Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
There are no upcoming events available at this time.
You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites.